High flow nasal cannula Global Market Report 2025

A high-flow nasal cannula (HFNC) is a medical device designed for delivering a high flow of heated and humidified oxygen-enriched air to patients with respiratory conditions. It comprises a lightweight tube connected to a machine that regulates the flow of air and oxygen. The cannula, placed in the patient's nostrils, administers a continuous stream of warm and moistened air at a higher flow rate compared to traditional oxygen therapy methods.

The primary types of high-flow nasal cannulas include air or oxygen blenders, nasal cannulas, active humidifiers, single-heated tubes, and others. Air-oxygen blenders are medical devices that blend air and oxygen to deliver a precise combination of oxygen and air to patients experiencing breathing difficulties or undergoing anesthesia. These devices find applications in various medical conditions such as acute respiratory failure, chronic obstructive pulmonary disease (COPD), carbon monoxide toxicity, bronchiectasis, sleep apnea, among others. High-flow nasal cannulas are distributed through diverse sales channels, including direct channels, and are utilized by various end-users, including hospitals and clinics, ambulatory care centers, long-term care centers, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The high-flow nasal cannula market research report is one of a series of new reports from The Business Research Company that provides high-flow nasal cannula market statistics, including high-flow nasal cannula industry global market size, regional shares, competitors with a high-flow nasal cannula market share, detailed high flow nasal cannula market segments, market trends and opportunities, and any further data you may need to thrive in the high flow nasal cannula industry. This high-flow nasal cannula market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The high flow nasal cannula market size has grown rapidly in recent years. It will grow from $5.61 billion in 2024 to $6.22 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising disposable income, changing lifestyle trends, globalization and trade, home renovation and construction activities, e-commerce growth.

The high flow nasal cannula market size is expected to see strong growth in the next few years. It will grow to $8.85 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to sustainable and eco-friendly products, changing demographics, smart textiles integration, interior design trends, health and wellness textiles. Major trends in the forecast period include smart home integration, sustainable materials and practices, customization and personalization, innovative textile technologies, digital retail experiences.

The forecast of 9.2% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on heated breathing circuits and precision oxygen blenders, sourced from key regions such as India and Ireland, which could lead to reduced respiratory support options and higher costs for critical care oxygen therapy.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The high-flow nasal cannula market is anticipated to experience growth due to the increasing incidence of asthma and COPD. Asthma, characterized by narrowed and inflamed airways with excessive mucus production, and COPD, a group of progressive lung diseases causing breathing difficulties, are contributing factors. The high-flow nasal cannula offers a potential treatment option by enhancing oxygen levels (PO2) while minimizing heart rate (HR) and respiratory rate (RR). This is particularly beneficial for severe bronchial asthma exacerbated by respiratory failure. Notably, in April 2023, Asthma + Lung UK reported a 149 percent surge in hospital admissions for children with asthma in England and Wales between 2021 and 2022, emphasizing the increasing prevalence of these respiratory conditions.

The high-flow nasal cannula market is poised for growth due to the expanding elderly population. Individuals aged 65 and older are considered part of this demographic, and the high-flow nasal cannula proves to be a safe and effective alternative for elderly patients with acute respiratory failure who may not respond to standard oxygen therapy, are intolerant of non-invasive ventilation (NIV) or continuous positive airway pressure (CPAP), and do not meet ICU admission criteria. In November 2022, the Office for National Statistics reported a significant milestone in England and Wales, with 18.6% of the population exceeding 11 million individuals falling within the 65-and-above age group. Notably, over half a million individuals (527,900) were at least 90 years old within this segment. Hence, the growing elderly population is a key driver behind the expansion of the high-flow nasal cannula market.

Major companies in the high-flow nasal cannula market are concentrating on advanced products such as the SoftFlow High-Flow Nasal Cannula to better serve their existing customers. The SoftFlow High-Flow Nasal Cannula is a breathing assistance device that provides patients with warm, humidified, oxygen-enriched air through a nasal cannula. For example, in 2024, Fisher & Paykel Healthcare, a New Zealand-based manufacturer and marketer of products and systems for acute and chronic respiratory care, surgery, and obstructive sleep apnea treatment, introduced the Airvo 2 device as part of the Optiflow Nasal High Flow Therapy system. This device delivers heated, humidified air and oxygen at high flow rates, enhancing oxygenation and reducing the work of breathing for patients suffering from COVID-19 and other respiratory ailments. Its optimal humidity levels support mucociliary function and decrease airway dryness, thus improving patient comfort. Furthermore, the device is designed for easy setup and use, making it appropriate for various hospital environments and contributing to better clinical outcomes.

In March 2022, Quantum Leap Healthcare Collaborative (QLHC), a US-based non-profit organization committed to advancing healthcare through collaborative research and clinical trials, along with NRx Pharmaceuticals, Inc. (NRx), announced the discontinuation of the nebulized form of ZYESAMI(R) (Aviptadil) in the I-SPY COVID Trial. This phase 2, open-label, adaptive platform trial, registered as NCT04488081, aimed to quickly evaluate potential treatments for severely and critically ill COVID-19 patients. The decision to halt the use of ZYESAMI(R) was made because it did not show the expected clinical benefits. NRx, a US-based clinical-stage biopharmaceutical company, specializes in developing treatments for COVID-19 and other respiratory illnesses.

Major companies operating in the high flow nasal cannula market report are Air Liquide Medical Systems Pvt. Ltd., Becton Dickinson and Company, Koninklijke Philips N.V., Teijin Pharma Limited, ResMed Inc., Dragerwerk AG & Co. KGaA, Teleflex Incorporated, Masimo Corporation, Medical Dynamics Inc., Fisher & Paykel Healthcare Corporation Limited, Smiths Medical Inc., Vyaire Medical Inc., DeVilbiss Healthcare LLC, Armstrong Medical Ltd., Vapotherm Inc., SunMed LLC, Medin Medical Innovations GmbH, Sterimed Group, MEK-ICS Co. Ltd., Narang Medical Limited, Breas Medical AB, Bio-Med Devices Inc., Flexicare Medical Ltd., Fairmont Medical Products Pty Ltd., Besmed Health Business Corp., Lowenstein GmbH & Co. KG, Great Group Medical Co. Ltd., TNI Medical AG, Guangdong Pigeon Medical Apparatus Co.Ltd., BLS Systems Limited

North America was the largest region in the high flow nasal cannula market in 2024. The regions covered in the high flow nasal cannula market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the high-flow nasal cannula (HFNC) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The high-flow nasal cannula (HFNC) market consists of sales of flow generators, oxygen blenders, nasal prongs, and humidifiers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

High flow nasal cannula Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on high flow nasal cannula market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for high flow nasal cannula ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The high flow nasal cannula market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Air Or Oxygen Blenders; Nasal Cannulas; Active Humidifier; Single Heated Tube; Other Types
• 2) By Application: Acute Respiratory Failure; Chronic Obstructive Pulmonary Disease (COPD); Carbon Monoxide Toxicity; Bronchiectasis; Sleep Apnea; Other Applications
• 3) By Sales Channel: Direct Channel; Distribution Channel
• 4) By End-User: Hospitals and clinics; Ambulatory care centers; Long-term care centers; Other End-Users
• Subsegments:
• 1) By Air or Oxygen Blenders: Manual Oxygen Blenders; Digital Oxygen Blenders
• 2) By Nasal Cannulas: Adult Nasal Cannulas; Pediatric Nasal Cannulas
• 3) By Active Humidifier: Heated Active Humidifiers; Non-Heated Active Humidifiers
• 4) By Single Heated Tube: Single Heated Tubes For Adult Use; Single Heated Tubes For Pediatric Use
• 5) By Other Types: Disposable High Flow Nasal Cannulas; Non-Invasive Ventilation (NIV) Interfaces
• Companies Mentioned: Air Liquide Medical Systems Pvt. Ltd.; Becton Dickinson and Company; Koninklijke Philips N.V.; Teijin Pharma Limited; ResMed Inc.; Dragerwerk AG & Co. KGaA; Teleflex Incorporated; Masimo Corporation; Medical Dynamics Inc.; Fisher & Paykel Healthcare Corporation Limited; Smiths Medical Inc.; Vyaire Medical Inc.; DeVilbiss Healthcare LLC; Armstrong Medical Ltd; Vapotherm Inc.; SunMed LLC; Medin Medical Innovations GmbH; Sterimed Group; MEK-ICS Co. Ltd.; Narang Medical Limited; Breas Medical AB; Bio-Med Devices Inc.; Flexicare Medical Ltd.; Fairmont Medical Products Pty Ltd; Besmed Health Business Corp.; Lowenstein GmbH & Co. KG; Great Group Medical Co. Ltd.; TNI Medical AG; Guangdong Pigeon Medical Apparatus Co.LTD; BLS Systems Limited
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.